134 related articles for article (PubMed ID: 11586807)
21. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake.
Suckling RM; Taegtmeyer M; Nguku PM; Al-Abri SS; Kibaru J; Chakaya JM; Tukei PM; Gilks CF
J Hosp Infect; 2006 Nov; 64(3):271-7. PubMed ID: 16926061
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
Van Damme P; Vorsters A
J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
[TBL] [Abstract][Full Text] [Related]
23. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
24. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
[TBL] [Abstract][Full Text] [Related]
25. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination.
Chen HL; Chang CJ; Kong MS; Huang FC; Lee HC; Lin CC; Liu CC; Lee IH; Wu TC; Wu SF; Ni YH; Hsu HY; Chen DS; Chang MH
Hepatology; 2004 Jan; 39(1):58-63. PubMed ID: 14752823
[TBL] [Abstract][Full Text] [Related]
26. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
[TBL] [Abstract][Full Text] [Related]
27. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk].
de Man RA
Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2365-6. PubMed ID: 18019211
[TBL] [Abstract][Full Text] [Related]
29. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
[TBL] [Abstract][Full Text] [Related]
30. [Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers].
van der Ploeg CP; Kateman H; Vermeer-de Bondt PE; Verkerk PH
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1820-4. PubMed ID: 15495511
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
32. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
33. [Vaccination scheme in advanced chronic kidney disease].
Barril G; Teruel JL
Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
Fabrizi F; Dixit V; Magnini M; Elli A; Martin P
Aliment Pharmacol Ther; 2006 Aug; 24(3):497-506. PubMed ID: 16886915
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and prevention of hepatitis B.
Alter MJ
Semin Liver Dis; 2003 Feb; 23(1):39-46. PubMed ID: 12616449
[TBL] [Abstract][Full Text] [Related]
36. [Chronic hepatitis B--still a problem in children].
Pohaci-Antonesei L; Bratu L; Rusu T; Moraru E
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):738-42. PubMed ID: 21243800
[TBL] [Abstract][Full Text] [Related]
37. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
38. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
[TBL] [Abstract][Full Text] [Related]
39. [Hepatitis B vaccination in France: vaccination coverage in 2002].
Denis F
Bull Acad Natl Med; 2004; 188(1):115-23. PubMed ID: 15368931
[TBL] [Abstract][Full Text] [Related]
40. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
